Sirolimus for treatment of β-thalassemia: from pre-clinical studies to the design of clinical trials
… The investigational drug in the form of coated tablets (0.5 mg sirolimus) is provided to the patients in blisters, adequately labelled with the information regarding the study. At visit 2 (V2, …..... Read More